|
|
|
 |
Last Updated: May 15, 2012 - 7:32:29 AM |
Latest Research
:
Rheumatology
:
Arthritis
:
Rheumatiod Arthritis
DNA-covered submicroscopic bead used to deliver genes to treat rheumatoid arthritis
A DNA-covered submicroscopic bead used to deliver genes or drugs directly into cells to treat disease appears to have therapeutic value just by showing up, researchers report.
In an animal model of rheumatoid arthritis, the enhanced expression of indoleomine 2,3 dioxygenase, or IDO, significantly reduced the hallmark limb joint swelling and inflammation of this debilitating autoimmune disease, researchers report in the study featured on the cover of The Journal of Immunology.
May 15, 2012 - 7:23:08 AM
|
Latest Research
:
Rheumatology
:
Arthritis
Rilonacept significantly reduced acute gout flares during uric acid-lowering therapy
A phase II clinical trial, published in Arthritis & Rheumatism, a journal of the American College of Rheumatology (ACR), found that rilonacept, an inhibitor of the protein interleukin-1 (IL-1), significantly reduced acute gout flares that occur when initiating uric acid-lowering therapy.
Jan 5, 2012 - 2:37:46 AM
|
Latest Research
:
Rheumatology
:
Arthritis
:
Ankylosing Spondylitis
Advances in genetics related to ankylosing spondylitis
Work done in part by researchers at The University of Texas Health Science Center at Houston has led to the discovery of two new genes that are implicated in ankylosing spondylitis (AS), an inflammatory and potentially disabling disease.
Jan 10, 2010 - 2:50:50 PM
|
Latest Research
:
Rheumatology
:
Arthritis
Is Devil's Claw the key to treating arthritis?
Deep in Africa's Kalahari desert lies the Devil's Claw, a plant that may hold the key to effective treatments for arthritis, tendonitis and other illnesses that affect millions each year.
Aug 17, 2009 - 3:48:25 PM
|
Latest Research
:
Rheumatology
Clinical studies of Regeneron's ARCALYST (rilonacept) published
Regeneron Pharmaceuticals, Inc. today announced the publication of the results of three studies which supported the U.S. Food and Drug Administration (FDA) regulatory submission for ARCALYST® (rilonacept) Injection for Subcutaneous Use for the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS).
Aug 11, 2008 - 8:28:24 AM
|
Latest Research
:
Rheumatology
:
Arthritis
High birth weight - risk for rheumatoid arthritis
People who have a birthweight over 10 pounds are twice as likely to develop rheumatoid arthritis when they are adults compared to individuals born with an average birthweight, according to a study published by researchers from Hospital for Special Surgery online in advance of print in the Annals of the Rheumatic Diseases.
Jun 30, 2008 - 8:40:12 AM
|
Latest Research
:
Rheumatology
Adalimumab- in rheumatic patients intolerant/unresponsive to other therapy
Adalimumab therapy is effective and well-tolerated in ankylosing spondylitis (AS), rheumatoid arthritis (RA) and psoriatic arthritis (PsA) patients with a previously inadequate response to anti-tumour necrosis factor (anti-TNF) therapies etanercept and infliximab, according to results of research presented today at EULAR 2008, the Annual European Congress of Rheumatology in Paris, France.
Jun 12, 2008 - 10:20:26 AM
|
Latest Research
:
Rheumatology
Stem cells offer cartilage repair hope for arthritis sufferers
Research presented on 11th April at the UK National Stem Cell Network Annual Science Meeting in Edinburgh could offer hope that bone stem cells may be harnessed to repair the damaged cartilage that is one of the main symptoms of osteoarthritis.
Apr 13, 2008 - 4:00:00 AM
|
Latest Research
:
Rheumatology
Fibromyalgia- an indepth look
Twenty-five years ago, Muhammad B. Yunus, MD, and colleagues published the first controlled study of the clinical characteristics of fibromyalgia syndrome. In the June 2007 issue of Seminars in Arthritis and Rheumatism, Dr. Yunus once again makes an enormous contribution to the field of chronic pain and fatigue by meticulously synthesizing and interpreting the extensive body of scientific literature on fibromyalgia.
Jun 25, 2007 - 11:49:39 AM
|
Latest Research
:
Rheumatology
Remicade therapy shown to increase productivity in psoriatic patients
Remicade (infliximab) is a Tumour Necrosis Factor(TNF) blocker drug classified as a biologic response modifier. The study has shown that patients with moderate to severe plaque psoriasis receiving REMICADE® (infliximab) induction and maintenance therapy experienced significant improvements in productivity at week 10, which were sustained through week 50.
Feb 3, 2007 - 6:52:29 AM
|
Latest Research
:
Rheumatology
Acupuncture effective in relieving low back pain, more cost-effective
Acupuncture has a small but significant benefit for patients with low back pain, and appears to be cost-effective in the longer term, find two studies published on bmj.com today.
Sep 15, 2006 - 6:05:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
:
Osteoarthritis
Matrilin-3 gene discovered to prevent onset of osteoarthritis
A gene that is associated with osteoarthritis and skeletal deformities in people has been shown to be responsible for preventing the onset of osteoarthritis in adult mice, according to a recent study led by Rhode Island Hospital. The matrilin-3 gene plays a role in early bone development, controls bone mineral density in adulthood and prevents osteoarthritis later in life.
Jul 24, 2006 - 7:17:00 PM
|
Latest Research
:
Rheumatology
:
Scleroderma
Cyclophosphamide Improves Breathing for Scleroderma Patients
An oral medication improves overall lung function and reduces lung-related inflammation associated with the deadly skin disease scleroderma, says a researcher at the University of Medicine and Dentistry of New Jersey who was part of a national study.
Jul 10, 2006 - 6:44:00 AM
|
Latest Research
:
Rheumatology
:
Arthritis
Rituximab halts damage to joints
New data, presented today at the Annual European Congress of Rheumatology show for the first time that a rheumatoid arthritis (RA) treatment, rituximab, is able to significantly inhibit the structural damage to joints caused by RA in patients who have long-standing disease and an inadequate response to one or more TNF (Tumour Necrosis Factor) inhibitors.
Jun 22, 2006 - 5:23:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
Tocilizumab effective in systemic juvenile idiopathic arthritis (sJIA)
A new study has confirmed significant improvements after treatment with tocilizumab amongst children with systemic juvenile idiopathic arthritis (sJIA), who do not tolerate or have an inadequate response to conventional therapies. Professor Shumpei Yokota presented the encouraging results of the first double-blind, placebo controlled trial for tocilizumab at the Annual European Congress of Rheumatology in Amsterdam today (Thursday 22 June)
Jun 22, 2006 - 4:44:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
:
Rheumatiod Arthritis
Unfavourable blood fat levels predict rheumatoid arthritis up to 10 years later
An unfavourable ratio of blood fats could herald the development of the inflammatory joint disease rheumatoid arthritis up to 10 years later, suggests research published ahead of print in the Annals of Rheumatic Diseases.
Jun 5, 2006 - 4:59:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
Role of inflammatory leukocytes in extending tissue damage
Documented in extensive studies, backed by the anecdotal evidence of professional athletes, impact injury to joints causes degeneration of cartilage. In most cases, the eventual result is the pain, stiffness, and compromised mobility of osteoarthritis (OA). Yet, questions remain surrounding the role of the inflammatory system in the cartilage destruction following mechanical trauma.
Apr 30, 2006 - 11:29:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
Rituximab achieves remission in patients resistant to conventional DMARDs
Drugs aimed at suppressing inflammation-provoking cytokines--specifically those linked to T-cells--have improved the treatment of rheumatoid arthritis (RA), a chronic, inflammatory autoimmune disease. Still, the frequency of remission achieved by these biologic agents remains below 50 percent. To increase the success rate of biologic therapy for RA patients, researchers have honed in on a new target: the B cell.
Apr 30, 2006 - 11:13:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
New hope for tissue regeneration and joint repair
Inflammation, cartilage and bone erosions, joint destruction--that's the typical progression of arthritis and most rheumatic diseases. While inflammation may be controlled, and perhaps even eliminated, with early aggressive treatment, few therapeutic approaches offer hope for repairing tissue once the damage has been done. One promising strategy is the use of mesenchymal stem cells (MSCs). MSCs are capable of extensive self-renewal and adaptable to forming all kinds of connective tissues. While detected in several adult human tissues, MSCs have traditionally been obtained from bone marrow, an invasive, painful, and costly process.
Mar 29, 2006 - 1:13:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
Fighting inflammation with targeted liposomal therapy
Vascular endothelial cells (VECs) form the walls of blood vessels and play a critical role in inflammation. In rheumatoid arthritis (RA), VECs interact with cytokines, proteins that regulate immune response, and allow inflammation to persist, escalate, and progressively damage tissue, and joints. Recognized as potent inflammation inhibitors, corticosteroids work to control the expression of cytokines, adhesion molecules and the growth of endothelial cells. The potential of these drugs, however, has been restricted by their considerable toxicity and short half-life.
Mar 29, 2006 - 1:08:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
Snake venom could ease arthritis pain
Snake venom could ease the debilitating pain from arthritis, say scientists.
Mar 29, 2006 - 12:56:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
Sodium Hyaluronate Can Fill the gap left by Cox-2 inhibitors
After the rise in safety concerns surrounding Vioxx and other Cox-2 inhibitors, people suffering from chronic shoulder pain were left with just two therapy options at opposite extremes - take Advil, or have surgery. But a new study from Columbia University Medical Center shows that sodium hyaluronate, a drug that is FDA-approved for osteoarthritis of the knee, is also effective for shoulder pain.
Mar 25, 2006 - 3:52:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
:
Rheumatiod Arthritis
Patients with severe Rheumatoid arthritis are at increased risk of developing lymphoma - New Study
An inflammatory disease of the immune system, rheumatoid arthritis (RA) is associated with increased occurrence of lymphoma--or cancers of the lymphatic system, which plays an integral role in the body's ability to fight infection. While various studies have affirmed this link, none have been able to pinpoint the specific effects of disease activity on lymphoma risk, let alone distinguish them from the effects of disease treatment.
Feb 27, 2006 - 5:54:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
:
Osteoarthritis
The link between meniscal damage and early onset osteoarthritis
This C-shaped tissue has many functions in the knee, including load bearing, shock absorption, and stability enhancement. The onset of knee OA after meniscectomy, the surgical removal of all or part of a torn meniscus, is fairly common and traditionally considered a result of the joint injury that leads to the operation in the first place.
Feb 27, 2006 - 5:49:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
Selective COX-2 inhibitors may still be best option for arthritis
Scientists believe that despite the current concerns around anti-inflammatory drugs like Vioxx, they may still be the best option for treating some forms of arthritis.
Jan 19, 2006 - 5:54:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
:
Rheumatiod Arthritis
Support for combination therapy for achieving remission of early rheumatoid arthritis
Two-year study of patients with early, aggressive disease demonstrates significantly superior results of anti-TNF plus DMARD therapy over either therapy alone
Jan 4, 2006 - 5:35:00 AM
|
Latest Research
:
Rheumatology
:
Arthritis
:
Rheumatiod Arthritis
Role of Type II Collagen in rheumatoid arthritis
Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the joints, which gradually erodes the cartilage and bone. The agents of destruction include inflammatory cells, cytokines, and protein-degrading enzymes known as matrix metalloproteinases (MMPs). The vicious cycle begins when inflammatory cells infiltrate the tissue lining the joints and consume excess oxygen. In addition to unleashing MMPs, the oxidative stress provokes non-enzymatic glycation â a chemical binding of sugar molecules and proteins. Telltale signs of glycation have been found in blood, urine, and synovial fluid of RA patients.
Dec 5, 2005 - 4:11:00 AM
|
Latest Research
:
Rheumatology
:
Arthritis
Study shows long-term benefits of initial combination therapy in RA
A progressive, inflammatory disease affecting the joints and organs, rheumatoid arthritis (RA) claims more than two million Americans, mostly women over age 40, among its victims. While a cure has yet to be found, the treatment of RA patients has changed considerably over the last two decades. Today, the goal of therapy is not simply symptom relief, but the prevention of long-term structural damage and functional decline. Toward this end, various disease-modifying antirheumatic drugs (DMARDs) have been proven effective in clinical trials, on their own and in tandem with various tumor necrosis factor (TNF) antagonists. While the recent increase in therapeutic options offers much promise, it has left doctors grappling with the question: What is the best treatment strategy for a patient newly diagnosed with RA?
Oct 30, 2005 - 2:16:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
Exercise May Strengthen Knee Cartilage in OA Patients
Osteoarthritis (OA) is the leading cause of disability among adults. As the population ages, increased intervention efforts are vital to controlling the individual and public health toll of this chronic, crippling joint disease. Along with early diagnosis, moderate exercise is one of the most effective ways to reduce pain and improve function in patients with OA of the knee and hip. Yet, more than 60 percent of U.S. adults with arthritis fail to meet the minimum recommendations for physical activity.
Oct 30, 2005 - 2:08:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
Synthetic protein PLAD shows potential in arthritis treament
A lab-made version of a human protein alleviates symptoms of both acute and chronic arthritis in mice and could be the basis for a new arthritis drug for people, report scientists from the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH). The protein prevents the assembly of a cell surface receptor, thus blocking transmission of chemical signals that lead to arthritis symptoms.
Oct 4, 2005 - 8:02:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
:
Rheumatiod Arthritis
Is the Disease Course of Rheumatoid Arthritis Becoming Milder?
Study affirms improving trend in the course of disease activity over the last decade, coinciding with more aggressive treatment strategies
Sep 4, 2005 - 8:14:00 AM
|
Latest Research
:
Rheumatology
:
Arthritis
New findings on menopausal arthritis
One of the most effective new treatments for breast cancer is a hormone therapy. Aromatase inhibitors work by powerfully blocking the conversion of androgen precursors into estrogens, which lowers estradiol levels in the bloodstream and estrogen levels in peripheral tissues. Because aromatase inhibitors reduce the rates of recurrence in women with early-stage postmenopausal breast cancer, these agents are not only becoming widely used in breast cancer treatment, but also being explored for their potential to prevent the disease in women at high risk.
Sep 4, 2005 - 7:23:00 AM
|
Latest Research
:
Rheumatology
:
Arthritis
Brightly-coloured fruit and veg may protect against arthritis
Researchers from The University of Manchester's Medical School have discovered that eating more brightly-coloured fruits and vegetables like oranges, carrots and sweetcorn may help reduce the risk of developing inflammatory disorders like rheumatoid arthritis.
Aug 18, 2005 - 2:17:00 AM
|
Latest Research
:
Rheumatology
:
Arthritis
Biologic drug adalimumab is effective in treating rheumatoid arthritis
There is good evidence that adding adalimumab (Humira) to the treatment of people with long-standing rheumatoid arthritis is more effective than using oral methotrexate alone.
Jul 20, 2005 - 3:07:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
Losing a pound results in a 4-pound reduction in knee-joint load for each step
The leading cause of disability in the United States, osteoarthritis (OA) is a complex, degenerative joint disease with several established risk factors. For OA of the knee, the most important modifiable risk factor is obesity. Both the American College of Rheumatology and the European League Against Rheumatism recommend weight loss and exercise to reduce the painful and incapacitating symptoms of knee OA.
Jun 29, 2005 - 1:04:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
Study shows effectiveness of doxycycline in slowing osteoarthritis progression
Jun 29, 2005 - 1:02:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
Knee injury causes decrease in lubrication
Researchers have found an association between inflammation from knee injuries and a progressive loss of joint lubrication, which may predispose people to arthritis. They have also found a way to quantify how much lubrication is lost following injury.
Jun 3, 2005 - 4:57:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
Study links TNF to androgen deficiency in rheumatoid arthritis
A protein involved in multiple cell functions, tumor necrosis factor (TNF) is perhaps best known for provoking destructive inflammation. Recently, drugs blocking the action of TNF have shown promise in the early treatment of rheumatoid arthritis (RA).
Jun 2, 2005 - 3:59:00 PM
|
Latest Research
:
Rheumatology
:
Arthritis
:
Ankylosing Spondylitis
Continuous NSAID use beneficial in ankylosing spondylitis
A widely under-recognized form of arthritis, ankylosing spondylitis (AS) is a chronic, progressive disease targeting the spine. Commonly striking in young adulthood, before age 35, AS causes inflammation, pain, and stiffness in the spinal joints--the vertebrae--and the sacroiliac joint, where the spinal column meets the pelvis. In advanced cases, this disease can result in deforming, crippling spinal fusion and organ damage. According to expert estimates, AS afflicts at least half a million people in the United States.
Jun 2, 2005 - 3:49:00 PM
|
<< prev
next >>
|
|
|
|
| Health |
Gathering information about food is not top priority for individuals with high metabolisms
|
NIH renews funding for University of Maryland vaccine research
|
DHA-enriched formula in infancy linked to positive cognitive outcomes in childhood
|
New IOM report lays out plan to determine effectiveness of obesity prevention efforts
|
Vitamin D supplementation may delay precocious puberty in girls
|
Study: Pedometer program helps motivate participants to sit less, move more
|
Fish oil may stall effects of junk food on brain
|
Intake of low energy dense food better than skipping meals
|
Inaugural IOF Olof Johnell Science Award presented to Professor Harry Genant
|
Molecular hub links obesity, heart disease to high blood pressure
|
| | Healthcare |
Healthcare experts from UK and India meet at the UK Parliament to discuss ways to improve health care in India, UK
|
Flu pandemic infected one in five
|
Stigma preventing leprosy-cured from getting jobs
|
Measles, Mumps make a comeback in US
|
Melinda Gates calls on Akhilesh Yadav
|
'Movies, TV impact tobacco users more than newspapers'
|
Rockland to open three new hospitals in NCR
|
Spice Global enters healthcare business with hospital in Delhi
|
Delhi to expedite recruitment of doctors
|
India adds spice to US life, keeps it healthy
|
| | Latest Research |
How do consumers see a product when they hear music?
|
Drug activates virus against cancer
|
Bone loss associated with increased production of ROS
|
Sound preconditioning prevents ototoxic drug-induced hearing loss in mice
|
Crystal methamphetamine use by street youth increases risk of injecting drugs
|
Johns Hopkins-led study shows increased life expectancy among family caregivers
|
Moderate to severe psoriasis linked to chronic kidney disease, say experts
|
Licensing deal marks coming of age for University of Washington, University of Alabama-Birmingham
|
Simple blood or urine test to identify blinding disease
|
Physician job satisfaction driven by quality of patient care
|
| | Medical News |
NHRC issues notice to Kerala over infant deaths
|
Advanced breast cancer detecting machine comes to India
|
'Dispel myths about vitiligo'
|
NHRC summons Odisha chief secretary
|
Woman dies of swine flu in UP
|
Maharashtra, GE to modernise rural health care
|
Hypertension: India's silent killer
|
Need cautious effort to eradicate polio: Experts
|
Ayurveda experts develop online personalised health regimen
|
Soon a detailed study on 'diabesity': Doctors
|
| | Special Topics |
MPs express anguish at Delhi gang-rape, Shinde assures fast trial
|
Worrying rise in number of medical students in prostitution over last 10 years
|
Behold India's unfolding democratic revolution
|
Chinese woman cuts open her belly to save surgery cost
|
Improved Sense of Smell Produced Smarter Mammals
|
Two-year-old world's first to have extra DNA strand
|
172,155 kidney stones removed from one patient!
|
'Primodial Soup' theory for origin of life rejected in paper
|
Human species could have killed Neanderthal man
|
History, geography also seem to shape our genome
|
|
|
